Registration Dossier

Toxicological information

Specific investigations: other studies

Currently viewing:

Administrative data

Link to relevant study record(s)

Description of key information

The potential of a structurally related substance, octyl-decyl trimellitate (L810TM) to induce testicular mal-development(TMD) has been studied in the rat and compared with the positive controls, di- (2-ethylhexyl) phthalate (DEHP) and its active metabolite, mono-(2-ethylhexyl) phthalate (MEHP). The effects of L810TM on the expression of genes in pathways involved in steroidogenesis and testes development previously shown to be involved in the induction of TMD by certain phthalate esters were studied using transcriptional profiling techniques on RNA extracted from the testes of rats exposed in utero to L810TM or the positive controls.

Additional information

Rats were exposed to L810TM in utero by the administration of daily oral gavage doses to pregnant dams between gestational day 12 and 19. The foetal testes were obtained by micro-dissection and prepared to facilitate the isolation of RNA, which was subsequently analysed using whole rat genome microarrays. The studies focussed on assessment of effects in pathways relevant to rat testicular mal-development (TMD). The effects of the two substances were compared with those of diethylhexyl phthalate (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP), an active metabolite of DEHP, both of which were used as a positive controls.

MEHP & DEHP (500 mg/Kg) caused a repression of genes in TMD pathways involved in cholesterol synthesis and transport (HMGCS, HMGCR, STAR, SCARB1, FDFT1, FDPS), Steroidogenesis (Cyp11a, HSD3B1, SC4MOL) and testes development (INSL3, INHA). L810TM did not cause significant repression of genes in TMD pathway.

In conclusion, it is highly unlikely that the substance will cause testicular mal-development in the rat under these treatment conditions.